Sort   by:  
 Page size 
TranscriptomicspcaGoPromoter - An R package for functional interpretation of principal component analysis of genome-wide gene expression data
Background and aim: Analysis of data obtained from genome wide gene expression experiments is challenging, due to the huge amount of variables, management of the data and the need for multivariate analysis. We here present the R package: pcaGoPromoter that facilitates the interpretation of genome wi...
ORGANISM(S): Homo sapiens 
2011-05-01 | E-GEOD-27071 | biostudies-arrayexpress
ProteomicsEffect of R. solanacearum infection in the xylem proteome of susceptible and tolerant tomato
Investigation of the impact of R. solanacearum infection in the xylem proteome of susceptible and tolerant tomato plants
ORGANISM(S): Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum) Solanum lycopersicum 
2025-03-27 | PXD058990 | Pride
Tomato Xylem Ralstonia infection 
UnknownTATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells.
Not available
S-EPMC10711561 | biostudies-literature
UnknownHomotaurine, a safe blood-brain barrier permeable GABAA-R-specific agonist, ameliorates disease in mouse models of multiple sclerosis.
Not available
S-EPMC6224391 | biostudies-literature
UnknownThe MC1R r allele does not increase melanoma risk in MITF E318K carriers.
Not available
S-EPMC10230961 | biostudies-literature
UnknownTCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data.
Not available
S-EPMC4856967 | biostudies-literature
UnknownUsing shRNA experiments to validate gene regulatory networks.
Not available
S-EPMC4535466 | biostudies-literature
UnknownMezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML.
Not available
S-EPMC11033588 | biostudies-literature
ProteomicsMezigdomide is effective alone and in combination with Menin inhibition in Acute Myeloid Leukemia
Small molecules that target the MENIN-KMT2A protein-protein interaction (Menin inhibitors) have recently entered clinical trials in lysine methyltransferase 2A (KMT2A, MLL1) rearranged (KMT2A-r) and nucleophosmin mutant (NPM1c) acute myeloid leukemia (AML) and are demonstrating encouraging results. ...
ORGANISM(S): Homo sapiens (Human) 
2024-02-15 | PXD041737 | Pride
Menin-kmt2a Menin inhibitor Acute myeloid leukemia Mezigdomide Ikaros 
ProteomicsMezigdomide is effective alone and in combination with Menin inhibition in Acute Myeloid Leukemia
Small molecules that target the MENIN-KMT2A protein-protein interaction (Menin inhibitors) have recently entered clinical trials in lysine methyltransferase 2A (KMT2A, MLL1) rearranged (KMT2A-r) and nucleophosmin mutant (NPM1c) acute myeloid leukemia (AML) and are demonstrating encouraging results. ...
ORGANISM(S): Homo sapiens (Human) 
2024-02-15 | PXD041735 | Pride
Menin-kmt2a Menin inhibitor Acute myeloid leukemia Mezigdomide Ikaros 
Sort   by:  
 Page size